Back to Agenda
Session 5: Brexit Time Check: What’s Next for Medicines?
Session Chair(s)
Peter O'Donnell
Journalist
Belgium
The aim of this session is to get to the broader level vision of what’s coming next in the Brexit schedule of change. This session will bring together a broad range of stakeholders to contribute their expectations, concerns and needs for the next stages of Brexit and the future partnership arrangements.
Speaker(s)
Robert Andrew Johnstone
Robert Andrew Johnstone
The International Foundation for Integrated Care (IFIC), United Kingdom
Patient Representative
Virginia Acha, PhD, MSc
Virginia Acha, PhD, MSc
Merck Sharp & Dohme LLC, United Kingdom
AVP, Global Regulatory Policy
Elizabeth Kuiper, MA
Elizabeth Kuiper, MA
European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium
Executive Director, Public Affairs
Oliver Sude, PhD
Oliver Sude, PhD
European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), Belgium
Legal Counsel, EU Affairs
Have an account?